Jaguar Health extends $2.57M convertible note maturity to Jan 30, 2026; issues new warrants at $2.70 strike

Jaguar Health, Inc.

Company entered Exchange Agreements with certain investors to replace ~$2.57M of 6% convertible notes originally due June 30, 2025; new maturity January 30, 2026.
Replacement Notes convertible at $5.535/sh (non-insider) or $5.555/sh (insider); New Warrants exercisable at $2.70/sh, expire in 18 months.
Insiders including CEO and board members participated in exchange, acquiring $492,012 principal of Replacement Notes and warrants for 177,138 shares.
Prior to extension, five investors converted $0.866M of original notes into equity.
Net proceeds from equity/debt financings or licensing above $8M must be used to repay Replacement Notes.

item 1.01item 2.03item 3.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.